Thomas Andrew Rowland - 12 Feb 2026 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
SVP, HEAD - ESTABLISHED BRANDS
Signature
/s/ Thomas Rowland, by attorney-in-fact Meredith W. Cook
Issuer symbol
ANIP
Transactions as of
12 Feb 2026
Net transactions value
-$80,932
Form type
4
Filing time
17 Feb 2026, 16:08:52 UTC
Previous filing
13 Feb 2026
Next filing
02 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS C/O ANI PHARMACEUTICALS, INC., 210 MAIN STREET WEST, BAUDETTE /s/ Thomas Rowland, by attorney-in-fact Meredith W. Cook 17 Feb 2026 0001507496

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Tax liability $43,412 -566 -1.4% $76.70 38,594 12 Feb 2026 Direct F1
transaction ANIP Common Stock Tax liability $37,520 -485 -1.3% $77.36 38,109 14 Feb 2026 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,958 shares of restricted stock, the grant of which was previously reported.
F2 Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,677 shares of restricted stock, the grant of which was previously reported.